Bicaverat Glucose 4.25% Calcium 1.75 mmol/L Peritoneal Dialysis Solution
Sodium Chloride 5.786g · Sodium Bicarbonate 2.94g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
MFDS item code 201902590 · Approved 2019.04.25 · Insurance code 664300641
Peritoneal dialysis treatment in patients with chronic renal failure
Peritoneal dialysis solution is used by patients with chronic kidney failure to remove waste from the blood. This solution facilitates the expulsion of unnecessary substances and excess fluid from the body via the peritoneum. Thus, it helps maintain homeostasis and correct electrolyte imbalances even when kidney function is impaired. Peritoneal dialysis solution is primarily used for the treatment of chronic kidney failure.
Generally, 2000 mL is infused into the peritoneal cavity 4 times daily and drained after 2~10 hours. The dose should be adjusted individually for each patient. If the patient experiences pain due to abdominal distension during peritoneal dialysis, first reduce the volume infused per exchange to 500~1500 mL. Increase the dose for patients with no residual renal function and a large body size; for these patients, or for patients who tolerate a larger infusion volume, the dose may be increased to 2500 mL per exchange. When peritoneal dialysis is performed intermittently or continuously using a peritoneal dialysis device, use a package size larger than the exchange volume per treatment (3,000 mL or 5,000 mL). If body weight exceeds the target dry weight, use a peritoneal dialysis solution with a higher glucose concentration (2.3 % or 4.25 %). The higher the glucose concentration of the peritoneal dialysis solution, the greater the volume of fluid removed. In this situation, care should be taken to keep the glucose load as low as possible while preserving peritoneal function and preventing dehydration.
For children, adjust the dose according to age, body size, and body weight (30~40 mL/kg).
This medication is a dialysis solution used to remove waste and excess fluid from the body through peritoneal dialysis. Stopping peritoneal dialysis prematurely may pose a risk to life if kidney replacement therapy is not conducted, hence caution is advised. This medication should not be used by patients with severe hypokalemia or hypercalcemia, hypotension, recent abdominal surgery or injury, severe abdominal inflammation, inflammatory bowel disease, peritonitis, abdominal fistula, intra-abdominal tumors, hernias, intestinal obstruction, lung disease, sepsis, hyperlipidemia, or severe weight loss. Additionally, this medication should be avoided in patients who cannot physically or mentally perform peritoneal dialysis properly. Caution should be exercised when using this medication in patients experiencing electrolyte loss due to vomiting or diarrhea, patients on calcium-containing medications, patients using digitalis preparations, patients taking diuretics, and diabetic patients, and if necessary, the electrolyte concentration of the dialysis solution or the dosage of blood glucose control medications should be adjusted. This medication plays a role in maintaining electrolyte balance but may cause adverse reactions such as hypokalemia, hypercalcemia, dehydration, fluid overload, blood glucose elevation, hyperlipidemia, and weight gain. Complications related to peritoneal dialysis may also occur, such as peritonitis, catheter infections, diarrhea, constipation, dyspnea, hernias, abdominal distension, shoulder pain, and encapsulating peritoneal sclerosis; if any unusual symptoms arise, consult a physician immediately. Prolonged peritoneal dialysis may impair peritoneal function and cause loss of protein and vitamins; therefore, nutritional status must be well managed. Regular monitoring of weight, blood electrolyte levels, protein levels, kidney function, etc., is important. This medication may affect the efficacy of other drugs, so dosage adjustments of concomitant medications may be necessary. Caution is required when using this medication during pregnancy or lactation, and in children, the dosage should be adjusted based on weight and age. The elderly are at higher risk for hernias and should be carefully evaluated before peritoneal dialysis. In the case of overdose, the dialysis solution should be drained to correct excess fluid and electrolyte imbalances, and the solution should be used within 24 hours after mixing. The solution should be stored in a tightly closed container to prevent exposure to air or moisture. Avoid using if the container is damaged or if the solution is cloudy, and handle the dialysis solution in a sterile manner to reduce infection risk. While this medication has a safety level due to its electrolyte composition similar to that of blood, careful management and regular monitoring are necessary during peritoneal dialysis.
Hypokalemia, hypercalcemia, rapid weight loss due to dehydration, hypotension, tachycardia, edema, hypertension, dyspnea, increased blood sugar, hyperlipidemia, weight gain, peritonitis, abdominal pain, fever, malaise, sepsis, erythema, edema, pain, exudate, crust, impairment during peritoneal dialysis fluid infusion and drainage, diarrhea, severe constipation, dyspnea due to diaphragm elevation, hernia, abdominal distension, bloating, shoulder pain, sclerosing peritonitis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should be in a cool place between 4 degrees and 25 degrees.
Before Mixing (Solution A, Solution B): Colorless, transparent peritoneal dialysis solution in a colorless, transparent plastic container. After Mixing (Mixed Solution): A colorless, transparent liquid separated into two spaces by a single membrane.
2000 milliliters/bag, 5000 milliliters/bag
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sodium Chloride 5.786g · Sodium Bicarbonate 2.94g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
Calcium Chloride Hydrate 4.41g · Magnesium Chloride Hexahydrate 2.033g +3 more
Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
Sodium Chloride 5.786g · Sodium Bicarbonate 2.94g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
Sodium Chloride 5.786g · Sodium Bicarbonate 2.94g +3 more
Solution · Prescription medication · Combination
Fresenius Medical Care Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.